A detailed history of Wolff Wiese Magana LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 15,761 shares of ABBV stock, worth $2.7 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares
15,761
Previous 16,183 2.61%
Holding current value
$2.7 Million
Previous $2.51 Million 14.48%
% of portfolio
2.53%
Previous 2.43%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $67,444 - $76,846
-422 Reduced 2.61%
15,761 $2.87 Million
Q4 2023

Jan 16, 2024

SELL
$137.6 - $154.97 $166,771 - $187,823
-1,212 Reduced 6.97%
16,183 $2.51 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $6,011 - $6,959
45 Added 0.26%
17,395 $2.59 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $1.25 Million - $1.56 Million
-9,455 Reduced 35.27%
17,350 $2.34 Million
Q1 2023

Apr 18, 2023

SELL
$144.61 - $166.54 $6,941 - $7,993
-48 Reduced 0.18%
26,805 $4.27 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $78,975 - $94,711
-571 Reduced 2.08%
26,853 $4.34 Million
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $7,381 - $8,466
55 Added 0.2%
27,424 $3.68 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $424,420 - $539,576
-3,084 Reduced 10.13%
27,369 $4.19 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $10,954 - $13,591
83 Added 0.27%
30,453 $4.94 Million
Q4 2021

Jan 18, 2022

SELL
$107.43 - $135.93 $44,153 - $55,867
-411 Reduced 1.34%
30,370 $4.11 Million
Q3 2021

Oct 15, 2021

BUY
$106.4 - $120.78 $57,562 - $65,341
541 Added 1.79%
30,781 $3.32 Million
Q2 2021

Jul 15, 2021

SELL
$105.21 - $117.21 $46,608 - $51,924
-443 Reduced 1.44%
30,240 $3.41 Million
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $76,315 - $84,014
746 Added 2.49%
30,683 $3.32 Million
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $2.41 Million - $3.25 Million
29,937 New
29,937 $3.21 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.